True Chromogranin A concentrations in plasma from patients with small intestinal neuroendocrine tumours
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Objective: The incidence of enteropancreatic neuroendocrine tumours (NET) is increasing. Chromogranin A (CgA) in plasma is a marker in patients suspected of NET tumours. CgA, however, is a precursor protein subjected to cellular processing that challenges quantitation and hence the use of CgA in diagnostics.Materials and methods: CgA concentrations in plasma sampled from 130 well-characterized patients with small intestinal NETs and from 30 healthy subjects were measured with eight commercial CgA kits, an in-house radioimmunoassay (RIA) and a processing-independent assay (PIA). For the evaluation of diagnostic accuracy, we performed regression analyses and plotted receiver-operating characteristic curves (ROC). The specificity was further assessed by size chromatography.Results: Five commercial assays (Thermo-Fisher, DRG Diagnostics, Eurodiagnostica (RIA and ELISA), and Phoenix), displayed a diagnostic accuracy with area under the curve (AUC) values >0.90, whereas three immunoassays (Yanaihara, CisBio RIA, and CisBio ELISA) discriminated poorly between disease stages (AUC: 0.60–0.78). Compared with the in-house assays, however, even the most accurate commercial immunoassay still missed patients with metastatic disease. Chromatography showed non-uniform patterns of large and small CgA fragments in plasma.Conclusion: Available commercial immunoassays measure CgA in plasma with gross variability. Three commercial CgA immunoassays discriminate so poorly between health and disease that they should not be used. The highest diagnostic accuracy was obtained with processing-independent measurement of total CgA concentrations in plasma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Plasma chromogranin A (CgA) is related to tumor burden and recommended in the follow-up of patients diagnosed with neuroendocrine tumors (NETs).”
From Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors (2020) · cites this paper as [18]
In the citing paper
“CgA PIA has demonstrated a high diagnostic accuracy (i.e., diagnostic sensitivity and specificity) compared to the CgA340-348 RIA and other CgA assays without trypsin cleavage prior to measurement [14,18].”
From Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors (2020) · cites this paper as [18]
In the citing paper
“All patients with metastatic disease had elevated CgA concentrations whereas half of patients with localized disease had elevated CgA, strengthening the idea that CgA is more sensitive in disseminated disease compared to localized disease [16,17,18,30,31].”
From Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors (2020) · cites this paper as [18]
In the citing paper
“In terms of diagnostic accuracy, the in-house CgA340-348 RIA was superior to all commercial assays and in accordance with the results from the present study—the highest diagnostic accuracy was obtained with CgA PIA [18].”
From Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors (2020) · cites this paper as [18]
In the citing paper
“Furthermore, diagnostic sensitivity and specificity depend on the assay type, analytic specificity and sensitivity of the antiserum employed [14], as does the fact that the CgA protein is heavily processed to smaller fragments [14,18,19,20].”
From Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors (2020) · cites this paper as [18]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649 · cited 2×
“Gel chromatography of plasma samples was performed on a Superose 12HR column; fractions were eluted with 0.02mol/ L phosphate buffer, pH 8.0, containing 0.25mol/L NaCl.”
MethodInfluentialpROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J.-N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4377 · Cited by 4,510
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
Lawrence, B., Gustafsson, B. I., Chan, A., Svejda, B., Kidd, M., & Modlin, I. M. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.12.005 · Cited by 861
The Chromogranin–Secretogranin Family
Taupenot, L., Harper, K. L., & O'Connor, D. T. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021405 · Cited by 819
OptimalCutpoints: An R Package for Selecting Optimal Cutpoints in Diagnostic Tests
López-Ratón, M., Rodríguez-Álvarez, M. X., Suárez, C. C., & Sampedro, F. G. (2014) · Journal of Statistical Software · doi:10.18637/jss.v061.i08 · Cited by 548
Öberg, K., Knigge, U., Kwekkeboom, D., & Perren, A. (2012) · Annals of Oncology · doi:10.1093/annonc/mds295 · Cited by 524
Self-citationENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
Niederle, B., Pape, U.-F., Costa, F., Gross, D., Kelestimur, F., Knigge, U., Öberg, K., Pavel, M., Perren, A., Toumpanakis, C., et al. (2016) · Neuroendocrinology · doi:10.1159/000443170 · Cited by 474 · cited 1×
“Classification, staging, and grading of small intestinal NETs were performed according to the ENETS guidelines, UICC classification and the WHO-AJCC 2019 classification [8,18].”
MethodSelf-citationNiederle, M. B., Hackl, M., Kaserer, K., & Niederle, B. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-10-0152 · Cited by 444
Research works printed but not linked: 1
- Helle KB, 2010, Results Probl Cell Differ, 50, 21
Cited by
Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs)
Effraimidis, G., Knigge, U., Rossing, M., Oturai, P., Rasmussen, Å. K., & Feldt‐Rasmussen, U. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.011 · Cited by 42
Self-citationLimited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors
Baekdal, J., Krogh, J., Klose, M., Holmager, P., Langer, S. W., Oturai, P., Kjaer, A., Federspiel, B., Hilsted, L., Rehfeld, J. F., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10110881 · Cited by 17
“None of the CgA fragments have better diagnostic accuracy than processing-independent analysis (PIA) of CgA [18].”
BackgroundMethodResultInfluentialSelf-citationOn premises and principles for measurement of gastrointestinal peptide hormones
Albrechtsen, N. J. W., & Rehfeld, J. F. (2021) · Peptides · doi:10.1016/j.peptides.2021.170545 · Cited by 15
Self-citationThe Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective
Mariën, L., Islam, O., Chhajlani, S., Lybaert, W., Peeters, M., Camp, G. V., de Beeck, K. O., & Vandamme, T. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-023-01147-3 · Cited by 11
Rehfeld, J. F., & Goetze, J. P. (2020) · Peptides · doi:10.1016/j.peptides.2020.170427 · Cited by 9
Self-citation
Metadata
- Authors
- Rehfeld, J. F., Broedbaek, K., Goetze, J. P., Knigge, U., & Hilsted, L. M.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Hilsted, Linda M.
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 2020-04-30
- Volume
- 55
- Issue
- 5
- Pages
- 565-573
- ISSN
- 0036-5521 (ISSN-L)
- 1502-7708
- OpenAlex
- W3022561214
- Cited by
- 13
- References
- 37
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2021: 5 · 2020: 2
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Scandinavian Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
- Keywords
- chromogranin A, small bowel neuroendocrine tumors, plasma biomarkers, metastasis detection, tumor markers
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Humans, Immunoassay, Intestinal Neoplasms, Male, Middle Aged, Pancreatic Neoplasms, Plasma, Regression Analysis, ROC Curve, Stomach Neoplasms, Biomarkers, Tumor, Neuroendocrine Tumors, Chromogranin A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: True Chromogranin A concentrations in plasma from patients with small intestinal neuroendocrine tumours. https://app.cochat.ai/papers/10.1080/00365521.2020.1759141
- The paper
- Rehfeld, J. F., Broedbaek, K., Goetze, J. P., Knigge, U., & Hilsted, L. M. (2020). True Chromogranin A concentrations in plasma from patients with small intestinal neuroendocrine tumours. Scandinavian Journal of Gastroenterology. https://doi.org/10.1080/00365521.2020.1759141
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.